Lumos Pharma Inc
F:4NX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lumos Pharma Inc
F:4NX1
|
US |
|
P
|
Procurri Corporation Ltd
OTC:PRCRF
|
SG |
|
Mabuchi Motor Co Ltd
OTC:MBUMF
|
JP |
|
Winking Studios Ltd
F:G4D
|
SG |
|
N
|
Noram Lithium Corp
F:N7R
|
CA |
|
Lumina Gold Corp
F:OMH2
|
CA |
|
Neuca SA
F:7HD
|
PL |
|
H
|
Hemogenyx Pharmaceuticals PLC
F:5HU
|
UK |
|
Nextplay Technologies Inc
F:6NI0
|
US |
|
H
|
Hysan Development Co Ltd
XMUN:HYN
|
HK |
|
M
|
Magnum Goldcorp Inc
F:1CJB
|
CA |
Shareholder Yield
Current shareholder yield for 
4NX1 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
4NX1 Price
Lumos Pharma Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -37% |
| Market Capitalization | 37.5m EUR |
| Shares Outstanding | 8 396 070 |
| Percentage of Shares Shorted |
N/A
|
4NX1 Return Decomposition
Main factors of price return
Stock Splits
4NX1's latest stock split occurred on Mar 19, 2020
The company executed a 1-for-9 stock split, meaning that for every 9 shares held, investors received 1 new share.
Before the split, 4NX1 traded at 0.865 per share. Afterward, the share price was about 7.5.
The adjusted shares began trading on Mar 19, 2020. This was the only stock split in 4NX1's history.
